Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Privitera

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Personalized Medicine|April 30, 2021
Personalized Clinical Phenotyping through Systems Medicine and Artificial IntelligenceAlfredo Cesario, Marika D'Oria, Francesco Bove, et al.
United European Gastroenterology Journal|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centreFranco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, et al.
Molecular Cancer Therapeutics|October 1, 2010
Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatmentMarco Ragusa, Alessandra Majorana, Luisa Statello, et al.
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Frontiers in Oncology|November 8, 2017
Corrigendum: Clinical and Research Activities at the CATANA Facility of INFN-LNS: From the Conventional Hadrontherapy to the Laser-Driven ApproachGiuseppe A P Cirrone, Giacomo Cuttone, Luigi Raffaele, et al.
Frontiers in Oncology|October 4, 2017
Clinical and Research Activities at the CATANA Facility of INFN-LNS: From the Conventional Hadrontherapy to the Laser-Driven ApproachGiuseppe A P Cirrone, Giacomo Cuttone, Luigi Raffaele, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 5, 2012
Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitorsMarco Ragusa, Luisa Statello, Marco Maugeri, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s updateLetizia Masi, Cristina Ciuffini, Valentina Petito, et al.
Biomedicines|April 23, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control StudyAlfredo Papa, Franco Scaldaferri, Marcello Covino, et al.
Cell|January 12, 2022
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosisNitish Rana, Giuseppe Privitera, Hannah C Kondolf, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Personalized Medicine|April 30, 2021
Personalized Clinical Phenotyping through Systems Medicine and Artificial IntelligenceAlfredo Cesario, Marika D'Oria, Francesco Bove, et al.
United European Gastroenterology Journal|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centreFranco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, et al.
Molecular Cancer Therapeutics|October 1, 2010
Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatmentMarco Ragusa, Alessandra Majorana, Luisa Statello, et al.
United European Gastroenterology Journal|March 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD studyGabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, et al.
Frontiers in Oncology|November 8, 2017
Corrigendum: Clinical and Research Activities at the CATANA Facility of INFN-LNS: From the Conventional Hadrontherapy to the Laser-Driven ApproachGiuseppe A P Cirrone, Giacomo Cuttone, Luigi Raffaele, et al.
Frontiers in Oncology|October 4, 2017
Clinical and Research Activities at the CATANA Facility of INFN-LNS: From the Conventional Hadrontherapy to the Laser-Driven ApproachGiuseppe A P Cirrone, Giacomo Cuttone, Luigi Raffaele, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 5, 2012
Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitorsMarco Ragusa, Luisa Statello, Marco Maugeri, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s updateLetizia Masi, Cristina Ciuffini, Valentina Petito, et al.
Biomedicines|April 23, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control StudyAlfredo Papa, Franco Scaldaferri, Marcello Covino, et al.
Cell|January 12, 2022
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosisNitish Rana, Giuseppe Privitera, Hannah C Kondolf, et al.
Pageof 10